(Press-News.org) WASHINGTON (March 30, 2014) — A first-ever randomized head-to-head comparison of two devices commonly used to treat the age-related disease aortic stenosis finds balloon-expandable transcatheter valves result in more successful procedures and relieve symptoms more frequently than self-expanding valves, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
Aortic stenosis is a condition in which a crucial valve in the heart ceases to function properly. The only cure is to replace the valve, either through open heart surgery or through transcatheter aortic valve replacement, a less-invasive option in which a replacement valve is threaded into the heart through an artery in the patient's leg.
"We know in general that the transcatheter approach works and that patients benefit from it," said Mohamed Abdel-Wahab, M.D., head of the cardiac catheterization laboratory at Segeberger Kliniken, Bad Segeberg, Germany, and senior author of the study. "But we have two main types of valves available for this procedure, and until now, there was no conclusive data about their relative effectiveness. This study is important because it's the first randomized comparison of these two technologies."
The researchers tracked 241 transcatheter valve-replacement procedures in five major hospitals in Germany. Half of the patients received a balloon-expandable valve, which is implanted by inflating a balloon that forces the valve into place. The other half received a self-expanding valve, which automatically expands when its sheath is removed.
The results show the balloon-expandable valve results in more successful procedures (the study's primary endpoint) and improved patient symptoms (one of the study's secondary endpoints). There was no significant difference between the groups for cardiovascular mortality at 30 days, bleeding and vascular complications or stroke. Successful procedures were those in which the valve was implanted in the correct position and provided a tight enough seal to prevent blood from leaking across the valve. Procedures using a balloon-expandable valve had a success rate of 95.9 percent as compared to 77.5 percent for the self-expanding valve.
Patients receiving the balloon-expandable valve also reported improvements in symptoms 30 days after the procedure at a rate of 94.3 percent compared to 86.7 percent in patients receiving a self-expanding valve. Common symptoms for aortic stenosis include breathlessness, chest pain, dizziness and palpitations.
"Symptoms improved for a majority of patients overall, but the improvements were more common in the patients who received a balloon-expandable valve," Abdel-Wahab said.
Abdel-Wahab speculated that the mechanics of the two valves may explain why the balloon-expandable option was generally more successful. The balloon-expandable valve may be better able to provide the amount of force needed to achieve a tight seal and prevent leakage.
Before 2002, open heart surgery was the only available treatment option for aortic stenosis. Many older patients are too frail to undergo such an invasive surgery, so transcatheter valve replacement was developed as a lower-risk solution for these patients or other patients who are not eligible for open heart surgery. The average age of patients in the study was 80.
Transcatheter aortic valve replacement has been used routinely in Europe since 2007 and in the United States since 2011. In the absence of conclusive studies comparing the balloon-expandable and self-expanding valves, operators have typically selected valves based on availability and the operator's own level of comfort with the technology.
"This is a very dynamic field," Abdel-Wahab said. "We now have new valves coming out that will probably be even better, but we do not have enough data about them yet. These results can help to inform the design of future devices."
The researchers will continue to monitor the patients for five years to compare long-term health outcomes in the two patient groups.
INFORMATION:
This study will be simultaneously published online in the Journal of the American Medical Association at the time of presentation.
The ACC's Annual Scientific Session brings together cardiologists and cardiovascular specialists from around the world each year to share the newest discoveries in treatment and prevention. Follow @ACCMediaCenter and #ACC14 for the latest news from the meeting.
The American College of Cardiology is a nonprofit medical society comprised of 47,000 physicians, surgeons, nurses, physician assistants, pharmacists and practice managers. The College is dedicated to transforming cardiovascular care, improving heart health and advancing quality improvement, patient-centered care, payment innovation and professionalism. The ACC also leads the formulation of important cardiovascular health policy, standards and guidelines. It bestows credentials upon cardiovascular specialists, provides professional education, supports and disseminates cardiovascular research, and operates national registries to measure and promote quality care. For more information, visit CardioSource.org.
Head-to-head study favors balloon-expandable transcatheter heart valves
Trial shows significant advantages over self-expanding valves for treating aortic stenosis
2014-03-31
ELSE PRESS RELEASES FROM THIS DATE:
Higher risks without cardio benefits halt study of aleglitazar
2014-03-31
WASHINGTON (March 30, 2014) — The phase III AleCardio trial was ended early when patients with type 2 diabetes and recent acute coronary syndrome who were treated with aleglitazar showed higher rates of heart failure, kidney events and gastrointestinal bleeding with no offsetting cardiovascular benefits, according to data presented at the American College of Cardiology's 63rd Annual Scientific Session. All other studies with the drug have been stopped as well.
Aleglitazar sparked interest for this patient population because of its dual action on two subtypes of the PPAR ...
Darapladib falls short in chronic coronary heart disease
2014-03-31
WASHINGTON (March 30, 2014) — The novel inflammation inhibitor darapladib showed no primary-endpoint advantage over placebo in patients with chronic coronary heart disease treated with a high level of background care, although it did suggest possible benefits for more specific coronary artery-related endpoints, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session. STABILITY is the first study to test this inflammation-prevention mechanism for reducing the likelihood that plaque will become an artery-blocking clot.
Darapladib ...
Evolocumab safely drops LDL cholesterol well below statin-only baseline
2014-03-31
WASHINGTON (March 30, 2014) — The monoclonal antibody evolocumab produced highly significant reductions in low-density lipoprotein (LDL) cholesterol, the "bad cholesterol," as an add-on to statins in all treatment groups, according to data from the LAPLACE-2 study presented at the American College of Cardiology's 63rd Annual Scientific Session.
LDL cholesterol is considered a major risk factor for cardiovascular disease. "High-risk patients – such as those with clinical cardiovascular disease, high LDL cholesterol levels or diabetes – are ideally treated with high-intensity ...
Anti-gout medication colchicine helps patients with recurrent pericarditis
2014-03-31
WASHINGTON (March 30, 2014) — A medication traditionally used to treat gout is also effective at treating recurrent pericarditis, an inflammation of the sac-like covering around the heart, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
In the first multicenter, double-blind trial to look at the use of colchicine for multiple recurrences of pericarditis, 240 patients were randomly assigned to either the study drug or placebo to examine the primary endpoint of recurrent pericarditis. The rate of disease recurrence ...
Renal denervation patient registry finds low rate of adverse events
2014-03-31
WASHINGTON (March 30, 2014) — Patients with uncontrolled high blood pressure treated with renal denervation had low rates of adverse events and significant lowering of blood pressure at six months, according to a registry-based study presented at the American College of Cardiology's 63rd Annual Scientific Session.
The Global SYMPLICITY Registry is the first and largest dataset of patients with uncontrolled hypertension treated with renal denervation. The open-label, multicenter study was established to examine the safety and effectiveness of the procedure. Outcomes presented ...
Post-approval study of transcatheter pulmonary valve completes 1 year
2014-03-31
WASHINGTON (March 30, 2014) — The first post-FDA approval study of a non-surgically implanted replacement pulmonary valve showed strong short- and mid-term results for the device in a small sample of patients with certain congenital heart defects, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
This multi-center study of 100 patients consecutively implanted with the Melody transcatheter pulmonary valve between July 2010 and July 2012 assessed the effectiveness of the device at six and 12 months based on the percentage ...
Cardiac resynchronization improves survival in heart failure patients
2014-03-31
WASHINGTON (March 30, 2014) — Patients in mild heart failure who receive a specialized pacemaker known as cardiac resynchronization therapy with a defibrillator (CRT-D) may live longer than those implanted with a traditional implantable cardioverter defibrillator (ICD), according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
In the first study to look at CRT-D in mildly symptomatic patients, researchers found that patients with left bundle branch block implanted with a CRT-D had a 41 percent reduced risk of death compared ...
Blood test helps predict heart attack risk for patients with chest pain
2014-03-31
WASHINGTON (March 30, 2014) — Patients presenting to the emergency department with an undetectable level of the blood biomarker high-sensitivity cardiac troponin T, and whose ECGs show no sign of restricted blood flow, have a minimal risk of heart attack within 30 days, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
In a study of all patients (14,636 in total) reporting to a Swedish emergency department with chest pain over a two-year period from 2010 to 2012, researchers examined patients' blood levels of high-sensitivity ...
The Atlantic Ocean dances with the sun and volcanoes
2014-03-31
Imagine a ballroom in which two dancers apparently keep in time to their own individual rhythm. The two partners suddenly find themselves moving to the same rhythm and, after a closer look, it is clear to see which one is leading.
It was an image like this that researchers at Aarhus University were able to see when they compared studies of solar energy release and volcanic activity during the last 450 years, with reconstructions of ocean temperature fluctuations during the same period.
The results actually showed that during the last approximately 250 years – since ...
Researchers reveal a new pathway through the sodium pump
2014-03-31
A study in The Journal of General Physiology provides new evidence that the ubiquitous sodium pump is more complex—and more versatile—than we thought.
The sodium pump is present in the surface membrane of all animal cells, using energy derived from ATP to transport sodium and potassium ions in opposite directions across the cell boundary. By setting up transmembrane gradients of these two ions, the pump plays a vital role in many important processes, including nerve impulses, heartbeats, and muscular contraction.
Now, Rockefeller University researchers Natascia Vedovato ...
LAST 30 PRESS RELEASES:
South Korea completes delivery of ITER vacuum vessel sectors
Global research team develops advanced H5N1 detection kit to tackle avian flu
From food crops to cancer clinics: Lessons in extermination resistance
Scientists develop novel high-fidelity quantum computing gate
Novel detection technology alerts health risks from TNT metabolites
New XR simulator improves pediatric nursing education
New copper metal-organic framework nanozymes enable intelligent food detection
The Lancet: Deeply entrenched racial and geographic health disparities in the USA have increased over the last two decades—as life expectancy gap widens to 20 years
2 MILLION mph galaxy smash-up seen in unprecedented detail
Scientists find a region of the mouse gut tightly regulated by the immune system
How school eligibility influences the spread of infectious diseases: Insights for future outbreaks
UM School of Medicine researchers link snoring to behavioral problems in adolescents without declines in cognition
The Parasaurolophus’ pipes: Modeling the dinosaur’s crest to study its sound #ASA187
St. Jude appoints leading scientist to create groundbreaking Center of Excellence for Structural Cell Biology
Hear this! Transforming health care with speech-to-text technology #ASA187
Exploring the impact of offshore wind on whale deaths #ASA187
Mass General Brigham and BIDMC researchers unveil an AI protein engineer capable of making proteins ‘better, faster, stronger’
Metabolic and bariatric surgery safe and effective for patients with severe obesity
Smarter city planning: MSU researchers use brain activity to predict visits to urban areas
Using the world’s fastest exascale computer, ACM Gordon Bell Prize-winning team presents record-breaking algorithm to advance understanding of chemistry and biology
Jeffrey Hubbell joins NYU Tandon to lead new university-wide health engineering initiative & expand the school’s bioengineering focus
Fewer than 7% of global hotspots for whale-ship collisions have protection measures in place
Oldies but goodies: Study shows why elderly animals offer crucial scientific insights
Math-selective US universities reduce gender gap in STEM fields
Researchers identify previously unknown compound in drinking water
Chloronitramide anion – a newly characterized contaminant prevalent in chloramine treated tap water
Population connectivity shapes cultural complexity in chimpanzees
Direct hearing tests show that minke whales can hear high-frequency sounds
Whale-ship collision risk mapped across Earth’s oceans
Bye-bye microplastics: new plastic is recyclable and fully ocean-degradable
[Press-News.org] Head-to-head study favors balloon-expandable transcatheter heart valvesTrial shows significant advantages over self-expanding valves for treating aortic stenosis